Ioxilan Systematic (IUPAC) name 1-N-(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-3-N-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Clinical data AHFS/Drugs.com Pregnancy cat. B(US) Legal status ℞-only (US) Routes intravenously Pharmacokinetic data Bioavailability N/A Protein binding negligible Half-life 2 hours Excretion Mostly renal Identifiers CAS number ATC code V08 PubChem ChemSpider UNII KEGG ChEMBL Chemical data Formula C18H24I3N3O8 Mol. mass 791.112 SMILES & (what is this?)
Ioxilan is a diagnostic contrast agent. It is injected intravenously before taking X-ray images to increase arterial contrast in the final image. It is marketed under the trade name Oxilan by Guerbet, L.L.C.
Contrast media (V08) X-ray and CTIodinated,
MRIParamagneticOtherPerflubron Ultrasound This pharmacology-related article is a stub. You can help Wikipedia by expanding it.